Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
<p style="text-align:justify;"> <b>Background:</b> Diffuse large B-cell lymphoma (DLBCL) comprises 31% of lymphomas in the United States. Although it is an aggressive type of lymphoma, 40% to 50% of patients are cured with treatment. The study objectives were to identify...
Үндсэн зохиолчид: | Griffiths, R, Gleeson, M, Knopf, K, Danese, M |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
BioMed Central
2010
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
-н: Gleeson Michelle, зэрэг
Хэвлэсэн: (2010-11-01) -
Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy.
-н: Danese, MD, зэрэг
Хэвлэсэн: (2016) -
Retrospective Evaluation of Patients Diagnosed with Diffuse Large B Cell Lymphoma (DLBCL)
-н: Atakan TEKİNALP, зэрэг
Хэвлэсэн: (2020-12-01) -
Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
-н: Griffiths, R, зэрэг
Хэвлэсэн: (2010) -
Interleukin 10 gene promoter polymorphism and risk of diffuse large B cell lymphoma (DLBCL)
-н: Roba M. Talaat, зэрэг
Хэвлэсэн: (2014-01-01)